A detailed history of Ls Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ls Investment Advisors, LLC holds 4,275 shares of AMGN stock, worth $1.33 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,275
Previous 4,135 3.39%
Holding current value
$1.33 Million
Previous $1.19 Million 2.1%
% of portfolio
0.2%
Previous 0.21%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $37,641 - $45,438
140 Added 3.39%
4,275 $1.22 Million
Q4 2023

Jan 12, 2024

SELL
$255.7 - $288.46 $29,405 - $33,172
-115 Reduced 2.71%
4,135 $1.19 Million
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $125,723 - $156,089
575 Added 15.65%
4,250 $1.14 Million
Q2 2023

Jul 20, 2023

BUY
$214.27 - $253.37 $582,814 - $689,166
2,720 Added 284.82%
3,675 $815,000
Q1 2023

Apr 26, 2023

BUY
$225.79 - $275.2 $215,629 - $262,816
955 New
955 $230,000
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $288,376 - $330,020
-1,450 Closed
0 $0
Q3 2021

Oct 21, 2021

SELL
$212.27 - $248.7 $10.7 Million - $12.5 Million
-50,460 Reduced 97.21%
1,450 $308,000
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $4.38 Million - $4.86 Million
-18,751 Reduced 26.54%
51,910 $12.7 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $861,454 - $1 Million
-3,882 Reduced 5.21%
70,661 $17.6 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $75,516 - $89,926
349 Added 0.47%
74,543 $17.1 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $511,302 - $568,610
-2,179 Reduced 2.85%
74,194 $18.9 Million
Q2 2020

Aug 10, 2020

SELL
$197.81 - $242.74 $15,429 - $18,933
-78 Reduced 0.1%
76,373 $18 Million
Q1 2020

Apr 20, 2020

SELL
$182.24 - $241.7 $267,710 - $355,057
-1,469 Reduced 1.89%
76,451 $15.5 Million
Q4 2019

Jan 31, 2020

SELL
$189.21 - $243.2 $181,641 - $233,472
-960 Reduced 1.22%
77,920 $18.8 Million
Q3 2019

Oct 31, 2019

SELL
$174.11 - $208.62 $95,760 - $114,741
-550 Reduced 0.69%
78,880 $15.3 Million
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $102,853 - $120,567
-617 Reduced 0.77%
79,430 $14.6 Million
Q1 2019

Apr 25, 2019

SELL
$180.87 - $203.88 $269,315 - $303,577
-1,489 Reduced 1.83%
80,047 $15.2 Million
Q4 2018

Feb 01, 2019

SELL
$178.4 - $208.25 $1.03 Million - $1.21 Million
-5,790 Reduced 6.63%
81,536 $15.9 Million
Q3 2018

Nov 13, 2018

SELL
$185.29 - $208.89 $353,903 - $398,979
-1,910 Reduced 2.14%
87,326 $18.1 Million
Q2 2018

Jul 20, 2018

SELL
$166.05 - $186.51 $1.07 Million - $1.21 Million
-6,469 Reduced 6.76%
89,236 $16.5 Million
Q1 2018

May 08, 2018

SELL
$169.43 - $198.0 $313,276 - $366,102
-1,849 Reduced 1.9%
95,705 $16.3 Million
Q4 2017

Feb 07, 2018

SELL
$168.79 - $188.59 $251,834 - $281,376
-1,492 Reduced 1.51%
97,554 $17 Million
Q3 2017

Oct 19, 2017

BUY
$167.29 - $191.0 $16.6 Million - $18.9 Million
99,046
99,046 $18.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ls Investment Advisors, LLC Portfolio

Follow Ls Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.